These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Dec 15, 2016
Study Will Focus on Cytomegalovirus, Epstein-Barr and Herpes Simplex Viruses
Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that it has initiated a research study to validate the ability of the Aethlon Hemopurifier® to capture viruses that are associated with...
Nov 18, 2016
In the midst of a devastating global crisis 2 years ago, a Ugandan physician was infected with Ebola in Sierra Leone as he was treating patients. He was hospitalized at the Frankfurt University...
Nov 10, 2016
Aethlon Medical, Inc. (Nasdaq: AEMD), a developer of immunotherapeutic technologies to combat infectious disease and cancer, today announced results for its fiscal second quarter year ended...
Nov 3, 2016
Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that it will host its Second Quarter Fiscal 2017 investor conference call and webcast on Thursday, November 10, 2016 at 4:30 p.m. Eastern...
Oct 13, 2016
Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that it has completed multiple milestone achievements under a contract with the Defense Advanced Research Projects Agency (DARPA), including a...